-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Integra Lifesciences Holdings Corp quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q1 2010 to Q1 2024.
- Integra Lifesciences Holdings Corp Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2024 was $15.8M, a 39.8% decline year-over-year.
- Integra Lifesciences Holdings Corp annual Net Cash Provided by (Used in) Operating Activities for 2023 was $140M, a 47.1% decline from 2022.
- Integra Lifesciences Holdings Corp annual Net Cash Provided by (Used in) Operating Activities for 2022 was $264M, a 15.4% decline from 2021.
- Integra Lifesciences Holdings Corp annual Net Cash Provided by (Used in) Operating Activities for 2021 was $312M, a 53.3% increase from 2020.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)